The Uterus Exhibiting Features Of The Stage 3 Endometriosis

Description

Centered on the uterine body, the animation surveys the serosal surface and adjacent pelvic reflections where stage 3 endometriosis typically declares itself. Deep infiltrating implants appear as irregular, dark nodules and plaque-like lesions along the posterior uterus near the uterosacral ligament insertions, with additional deposits extending laterally toward the broad ligament and adnexal region. As the sequence progresses, lesions enlarge and deepen relative to the myometrium, and fibrotic tethering becomes more apparent where the posterior uterine wall approaches the rectouterine pouch (pouch of Douglas). Spatial relationships stay clear: anterior uterine contour remains comparatively smooth while posterior and posterolateral surfaces carry the dominant disease burden. Stage 3 (moderate) endometriosis sits in the gray zone between superficial peritoneal implants and the dense obliteration seen in stage 4, and that distinction affects both counseling and operative planning. Deep lesions and traction bands help explain dysmenorrhea, deep dyspareunia, and cyclic bowel symptoms when implants involve the posterior compartment or uterosacral ligaments, and they raise the likelihood of ureteral proximity during dissection near the uterine artery and cardinal ligament. Motion matters here. The animated build-up from scattered implants to larger, deeper lesions makes the concept of infiltration and fibrosis easier to teach than a single still, and it supports discussion of why laparoscopic excision can be technically demanding even without massive endometriomas. Use this asset for gynecology and reproductive endocrinology lectures, patient-facing education on surgical staging, and medical publishing on pelvic pain, infertility workups, or laparoscopic mapping of endometriosis. It also fits simulation curricula that contrast rASRM stage 3 findings with endometriosis phenotypes in the posterior compartment. Anatomical accuracy verified by SciePro's Medical Advisory Board.